Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by WORKINMONTANAon Apr 29, 2021 9:58am
131 Views
Post# 33090228

RE:I must say…

RE:I must say…

Large financially backed Countries/companies force companies with leading edge technology into insolvency all the time across the world.  It could be China, South Korea, Hong Kong firms or even the Cartel in Columbia.  No one will know who sells millions upon millions of shares into the open market to keep Claritas market cap at mere pennies all these years. Their MC should be upwards of $200 million currently but the market makers will not allow it. Manipulation at its finest 


just to name a few
Nokia
Apple
IBM
Nortel
Delta
Opiti Canada
Nintendo
Lego


Im not looking to get into an argument, all you fat trolls can eat dog do do, 

Claritas has the parts to get back to the new normal, but you all are holding it back. Shameful 
 

<< Previous
Bullboard Posts
Next >>